| 000 | 00956 a2200265 4500 | ||
|---|---|---|---|
| 005 | 20250517105553.0 | ||
| 264 | 0 | _c20160722 | |
| 008 | 201607s 0 0 eng d | ||
| 022 | _a1176-6336 | ||
| 024 | 7 |
_a10.2147/TCRM.S80732 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGhidini, Michele | |
| 245 | 0 | 0 |
_aNew developments in the treatment of chemotherapy-induced neutropenia: focus on balugrastim. _h[electronic resource] |
| 260 |
_bTherapeutics and clinical risk management _c2016 |
||
| 300 |
_a1009-15 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 700 | 1 | _aHahne, Jens Claus | |
| 700 | 1 | _aTrevisani, Francesco | |
| 700 | 1 | _aPanni, Stefano | |
| 700 | 1 | _aRatti, Margherita | |
| 700 | 1 | _aToppo, Laura | |
| 700 | 1 | _aTomasello, Gianluca | |
| 773 | 0 |
_tTherapeutics and clinical risk management _gvol. 12 _gp. 1009-15 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2147/TCRM.S80732 _zAvailable from publisher's website |
| 999 |
_c26253605 _d26253605 |
||